Publikationen, an denen er mitarbeitet Antoni Torres Martí (20)

2023

  1. Effect of viral storm in patients admitted to intensive care units with severe COVID-19 in Spain: a multicentre, prospective, cohort study

    The Lancet Microbe, Vol. 4, Núm. 6, pp. e431-e441

2022

  1. Higher frequency of comorbidities in fully vaccinated patients admitted to the ICU due to severe COVID-19: a prospective, multicentre, observational study

    The European respiratory journal, Vol. 59, Núm. 2

  2. Low anti-SARS-CoV-2 S antibody levels predict increased mortality and dissemination of viral components in the blood of critical COVID-19 patients

    Journal of Internal Medicine, Vol. 291, Núm. 2, pp. 232-240

  3. Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study

    Intensive Care Medicine, Vol. 48, Núm. 7, pp. 850-864

  4. Methodology of a Large Multicenter Observational Study of Patients with COVID-19 in Spanish Intensive Care Units

    Archivos de Bronconeumologia, Vol. 58, pp. 22-31

  5. N-antigenemia detection by a rapid lateral flow test predicts 90-day mortality in COVID-19: A prospective cohort study

    Clinical Microbiology and Infection, Vol. 28, Núm. 10, pp. 1391.e1-1391.e5

  6. One-year mortality after ICU admission due to COVID-19 infection

    Intensive Care Medicine

2021

  1. Circulating microRNA profiles predict the severity of COVID-19 in hospitalized patients

    Translational Research, Vol. 236, pp. 147-159

  2. Combining immunomodulators and antivirals for COVID-19 – Authors' reply

    The Lancet Microbe

  3. Correction to: The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients (Critical Care, (2021), 25, 1, (331), 10.1186/s13054-021-03727-x)

    Critical Care

  4. Mounting evidence of impaired viral control in severe COVID-19

    The Lancet Microbe

  5. The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity

    The Lancet Respiratory Medicine, Vol. 9, Núm. 6, pp. 622-642

  6. The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients

    Critical Care, Vol. 25, Núm. 1

2020

  1. COVID-19 as a cardiovascular disease: the potential role of chronic endothelial dysfunction

    Cardiovascular research, Vol. 116, Núm. 10, pp. e132-e133

  2. Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19

    Critical Care, Vol. 24, Núm. 1

2019

  1. Lymphocytopenia as a predictor of mortality in patients with ICU-acquired pneumonia

    Journal of Clinical Medicine, Vol. 8, Núm. 6

2017

  1. Immunological profiling to assess disease severity and prognosis in community-acquired pneumonia

    The Lancet Respiratory Medicine

  2. Lymphopenic Community Acquired Pneumonia (L-CAP), an Immunological Phenotype Associated with Higher Risk of Mortality

    EBioMedicine, Vol. 24, pp. 231-236

2014

  1. IgA level in plasma as a differential factor for influenza infection in severe viral pneumonia

    Journal of Clinical Virology

2013

  1. IgM levels in plasma predict outcome in severe pandemic influenza

    Journal of Clinical Virology, Vol. 58, Núm. 3, pp. 564-567